Results 11 to 20 of about 9,895 (222)

Rapid PBPK modeling with the httk model [PDF]

open access: yes, 2018
A Course on Physiologically Based Pharmacokinetic (PBPK) Modeling Given at ScitoVation Nov ...
John Wambaugh (230167)
openaire   +2 more sources

Prediction of Monoclonal Antibody Pharmacokinetics in Pediatric Populations Using PBPK Modeling and Simulation [PDF]

open access: yesPharmaceutics
Background: Accurately determining pediatric dosing is essential prior to initiating clinical trials or administering medications in routine clinical settings. In children, ethical considerations demand careful evaluation of both safety and effectiveness.
Chiara Zunino   +4 more
doaj   +2 more sources

Comparing computational times for simulations when using PBPK model template and stand-alone implementations of PBPK models

open access: yesFrontiers in Toxicology
IntroductionWe previously developed a PBPK model template that consists of a single model “superstructure” with equations and logic found in many physiologically based pharmacokinetic (PBPK) models.
Amanda S. Bernstein   +3 more
doaj   +3 more sources

Predictive modelling and simulation for taming the chance and luck in biologics drug discovery [PDF]

open access: yesProceedings of the Estonian Academy of Sciences, 2023
Three Pillars of Survival paradigm in the pharmaceutical drug discovery stipulates that a drug candidate is more likely to reach Phase III if it meets the following criteria: 1) it reaches the required tissue compartment, 2) engages the desired target, 3)
Armin Sepp
doaj   +1 more source

Exploring Tafamidis Effects Through PBPK-QSP Modelling. [PDF]

open access: yesPharmaceutics
Background/Objectives: Tafamidis, a transthyretin kinetic stabilizer, increases circulating transthyretin levels in treated patients. While this effect is well documented, its underlying mechanism remains incompletely understood. This study aimed to evaluate the performance of a Physiologically Based Pharmacokinetic (PBPK) model performance and to ...
Ulaszek S   +3 more
europepmc   +5 more sources

A perspective on the current use of the phase distribution model for predicting milk‐to‐plasma drug concentration ratio

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2022
The phase distribution model, proposed by Atkinson and Begg in 1990, has been widely used for predicting breastmilk‐to‐plasma drug concentration ratio. However, misrepresentations of the equations have been noted in recent publications.
Mian Zhang   +5 more
doaj   +1 more source

The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development [PDF]

open access: yesArhiv za farmaciju, 2021
Computer-based (in silico) modeling & simulation tools have been embraced in different fields of pharmaceutics for a variety of applications. Among these, physiologically-based pharmacokinetic/biopharmaceutics modeling (PBPK/PBBM) emerged as a ...
Cvijić Sandra   +3 more
doaj   +1 more source

Review of the pharmacokinetics of nanodrugs

open access: yesNanotechnology Reviews, 2023
Nanodrug delivery systems (NDDSs) are a hotspot of new drug delivery systems with great development potential. They provide new approaches to fighting against diseases.
Shao Xiaotong   +4 more
doaj   +1 more source

Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model [PDF]

open access: yesCPT: Pharmacometrics & Systems Pharmacology, 2016
The aim of this tutorial is to introduce the fundamental concepts of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling with a special focus on their practical implementation in a typical PBPK model building workflow. To illustrate basic steps in PBPK model building, a PBPK model for ciprofloxacin will be constructed and coupled ...
Kuepfer, L   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy